What Happened?
Vancouver, WA-based Absci Appointed Andreas Busch as Chief Innovation Officer
About the Company
Absci is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. We built our Integrated Drug Creation™ Platform to accelerate discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to develop new protein-based drugs, including those that may be impossible to make with other technologies. Our goal is to enable the creation of better medicines by Translating Ideas into Drugs.
About the Person
Andreas Busch is Chief Innovation Officer at Absci. Previously, Andreas held various senior IT leadership roles in the industry.
Info Source
News
Short Profile